Point72

Portfolio Co Investors 2026 for Point72: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Point72 accounts for 10 tracked companies with verified cap-table data, 10 of which disclose round sizes totalling $2.2B. The median disclosed raise is $135M, and the largest is Mirador Therapeutics at $650M, ahead of Prometheus Biosciences ($400M) and Delfi Diagnostics ($400M).

The names that recur most often on these co-invested cap tables are Point72 (10 companies), Farallon Capital Management (4 companies), OrbiMed (3 companies), Sanofi Ventures (2 companies), T. Rowe Price (2 companies), Fairmount (2 companies). By latest disclosed round, the market skews Series C (3), Series B (2), Series A (2).

Best funded Point72 companies

  1. Mirador Therapeutics — $650M (latest: Series B)
  2. Prometheus Biosciences — $400M (latest: Series A)
  3. Delfi Diagnostics — $400M (latest: Series B)
  4. TONIK — $150M
  5. Ajax Therapeutics — $135M (latest: Series C)
  6. BioTheryX — $127M
  7. Botkeeper — $100M
  8. Rivet Industries — $90M (latest: Series A)
  9. Anvilogic — $85M (latest: Series C)
  10. Caribou Biosciences — $40M (latest: Series C)

Point72 Ventures (p72.vc) — related firms and companies (56)

Point72 Ventures (p72.vc) profile · All research reports